Advertisement
Research Article

Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device

  • Brian J. Kirby mail,

    bk88@cornell.edu (BJK); pag2015@med.cornell.edu (PG)

    Affiliations: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, United States of America, Biomedical Engineering, Cornell University, Ithaca, New York, United States of America

    X
  • Mona Jodari,

    Affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Matthew S. Loftus,

    Affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Gunjan Gakhar,

    Affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Erica D. Pratt,

    Affiliations: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, United States of America, Biomedical Engineering, Cornell University, Ithaca, New York, United States of America

    X
  • Chantal Chanel-Vos,

    Affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Jason P. Gleghorn,

    Affiliations: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, United States of America, Biomedical Engineering, Cornell University, Ithaca, New York, United States of America

    X
  • Steven M. Santana,

    Affiliations: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, United States of America, Biomedical Engineering, Cornell University, Ithaca, New York, United States of America

    X
  • He Liu,

    Affiliation: Department of Urology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • James P. Smith,

    Affiliations: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, United States of America, Biomedical Engineering, Cornell University, Ithaca, New York, United States of America

    X
  • Vicente N. Navarro,

    Affiliation: Department of Urology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Scott T. Tagawa,

    Affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Neil H. Bander,

    Affiliation: Department of Urology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • David M. Nanus,

    Affiliations: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America, Department of Urology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Paraskevi Giannakakou mail

    bk88@cornell.edu (BJK); pag2015@med.cornell.edu (PG)

    Affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York, United States of America

    X
  • Published: April 27, 2012
  • DOI: 10.1371/journal.pone.0035976

Reader Comments (0)

Post a new comment on this article